Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Solventum Corporation (SOLV) Stock Price & Analysis

309 Followers

SOLV Stock Chart & Stats

$88.62-$1.46(-1.62%)
At close: 4:00 PM EST
$85$90Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$88.46 - $90.26
52-Week Range
$62.38 - $94.16
Previous Close
$90.08
Volume
N/A
Average Volume (3M)
1.21M
Market Cap
$15.29B
Enterprise Value
$19.88B
Total Cash (Recent Filing)
$451.00M
Total Debt (Recent Filing)
$5.27B
Price to Earnings (P/E)
99.6
Beta
0.73
Next Earnings
Mar 04, 2027 (Est.)
EPS Estimate
1.77
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

HIS Software Growth

Health Information Systems is showing organic growth alongside strong customer retention and rising adoption of revenue-cycle and AI coding solutions. Continued use of these software offerings can deepen customer relationships, support recurring demand, and diversify Solventum beyond procedure-driven products.

Product Innovation And Market Expansion

Acera’s strong growth and the regulatory clearance for combined Restrata and V.A.C. use expand Solventum’s commercial offering in wound care. These developments can improve clinical utility, broaden adoption, and create durable cross-selling opportunities through an established provider base.

Structural Cost Improvement

Renegotiating the supply agreements removes a known future cost increase and protects the economics of affected products beyond the next few quarters. Combined with ongoing footprint and transformation work, this improves margin visibility and preserves resources for investment.

Bears Say

Profitability Deterioration

The sharp decline in net and operating margins indicates that recent earnings power is substantially weaker than in prior years. Until profitability recovers consistently, Solventum may have less capacity to fund investment, absorb cost pressure, or convert revenue growth into durable shareholder returns.

Weak Cash Generation

Near-zero or negative recent free cash flow weakens financial flexibility and raises concern about the quality of reported earnings. Sustained cash conversion is important for funding separation costs, reducing debt, and supporting capital allocation without relying more heavily on external financing.

Leverage And Financial Flexibility

Debt near the level of equity limits Solventum’s room to respond to operational setbacks or invest aggressively through a weaker cycle. Leverage also increases sensitivity to financing costs and makes strong, repeatable cash generation more important for maintaining strategic flexibility.

Solventum Corporation News

SOLV FAQ

What was Solventum Corporation’s price range in the past 12 months?
Solventum Corporation lowest stock price was $62.38 and its highest was $94.16 in the past 12 months.
What is Solventum Corporation’s market cap?
Solventum Corporation’s market cap is $15.29B.
When is Solventum Corporation’s upcoming earnings report date?
Solventum Corporation’s next earnings report is estimated for Mar 04, 2027 (not yet confirmed), which is in 112 days.
How were Solventum Corporation’s earnings last quarter?
Solventum Corporation released its earnings results on Nov 05, 2026. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.342 by $0.108.
Is Solventum Corporation overvalued?
According to Wall Street analysts Solventum Corporation’s price is currently Undervalued.
Does Solventum Corporation pay dividends?
Solventum Corporation does not currently pay dividends.
What is Solventum Corporation’s EPS estimate?
Solventum Corporation’s EPS estimate is 1.77.
How many shares outstanding does Solventum Corporation have?
Solventum Corporation has 169,739,330 shares outstanding.
What happened to Solventum Corporation’s price movement after its last earnings report?
Solventum Corporation reported an EPS of $1.45 in its last earnings report, beating expectations of $1.342. Following the earnings report the stock price went up 3.671%.
Which hedge fund is a major shareholder of Solventum Corporation?
Hedge funds hold Solventum Corporation shares: the largest hedge-fund position in Solventum Corporation is 70,122,183 shares, and hedge funds decreased their holdings by 443.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology